INS and diabetes mellitus: DM, characterized by chronic hyperglycemia due to defects in insulin secretion, insulin action, or both, has reached epidemic proportions, affecting approximately 589 million adults worldwide in 2024, with projections indicating a rise to 853 million by 2050 [1].